0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Review Article |  FREE
Arnaud Chiolero, MD, PhD; Pascal Bovet, MD, MPH; Gilles Paradis, MD, MSc
JAMA Pediatr. 2013;167(3):266-273. doi:10.1001/jamapediatrics.2013.438.

Article |  FREE
Susanna Saarilehto, MPsych; Helena Lapinleimu, MD, PhD; Soili Keskinen, DPsych; et al.
Arch Pediatr Adolesc Med. 2003;157(8):753-758. doi:10.1001/archpedi.157.8.753.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Research Letter  | 
Trends in Predicted Risk for Atherosclerotic Cardiovascular Disease Using the Pooled Cohort Risk Equations Among US Adults From 1999 to 2012
Earl S. Ford, MD, MPH; Julie C. Will, PhD; Carla I. Mercado, PhD; et al.
JAMA
Original Investigation  | 
Association of Inpatient vs Outpatient Onset of ST-Elevation Myocardial Infarction With Treatment and Clinical Outcomes
Prashant Kaul, MD; Jerome J. Federspiel, PhD; Xuming Dai, MD; et al.
JAMA Dermatology
JAMA Dermatology Clinicopathological Challenge  | 
A Purpuric Patch on the Flank
Ohara Aivaz, MD; Mamina M. Turegano, MD; Arash Radfar, MD, PhD
JAMA Internal Medicine
Viewpoint  | 
Secondary Prevention of Cardiovascular Disease With Vorapaxar:  A New Era of 3-Drug Antiplatelet Therapy?
Mori J. Krantz, MD; Sanjay Kaul, MD